Symbol="ZNTL"
AssetType="Common Stock"
Name="Zentalis PharmaceuticalsÂ Llc"
Description="Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment of various cancers. The company is headquartered in New York, New York."
CIK="1725160"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="530 SEVENTH AVENUE, SUITE 2201, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1796607000"
EBITDA="-222856992"
PERatio="None"
PEGRatio="None"
BookValue="7.41"
DividendPerShare="0"
DividendYield="0"
EPS="-4.22"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.236"
ReturnOnEquityTTM="-0.573"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-4.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="49.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.661"
EVToRevenue="-"
EVToEBITDA="-3.24"
Beta="1.791"
num_52WeekHigh="31.49"
num_52WeekLow="15.55"
num_50DayMovingAverage="26.8"
num_200DayMovingAverage="22.62"
SharesOutstanding="70510000"
DividendDate="None"
ExDividendDate="None"
symbol="ZNTL"
open="25.17"
high="26.05"
low="25.11"
price="25.71"
volume="316466.00"
latest_trading_day="2023-08-18"
previous_close="25.48"
change="0.23"
change_percent="0.9027%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="35"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="790946"
Change_recent_avg="0.06"
Delta_recent_avg="1.33"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="531"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
